Actively Recruiting
Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India
Led by International Agency for Research on Cancer · Updated on 2026-04-03
5500
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
Sponsors
I
International Agency for Research on Cancer
Lead Sponsor
D
Department of Health and Family welfare, Government of Sikkim
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.
CONDITIONS
Official Title
Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 22 years, resident of Sikkim and married.
- Pregnancy will not be considered as exclusion criteria.
- Sample collection should be avoided during active menstruation.
You will not qualify if you...
- Women who do not provide written consent.
- Women unable to cooperate in collection of cervical cell samples or respond to questions due to acute or severe mental or physical illnesses.
- Women who have had a hysterectomy.
- Women vaccinated in a research project.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sikkim Manipal Hospital
Gangtok, Sikkim, India, 737107
Actively Recruiting
Research Team
P
Partha Basu, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here